Overview of Dr. Tchang
Dr. Beverly Tchang is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Weill Cornell and New York-Presbyterian Hospital. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 6 years. She specializes in diabetes, lipid metabolism, and obesity and is experienced in nutrition, obesity and obesity-related disorders, and menopause.
Office
1305 York Ave.
4th Floor
New York, NY 10021
Education & Training
- New York Presbyterian HospitalFellowship, Obesity Medicine, 2018 - 2019
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2018
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2013 - 2016
- State University of New York Downstate Medical Center College of MedicineClass of 2013, MD, AOA
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2017 - 2026
- NJ State Medical License 2022 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
- North American Menopause SocietyCertified Menopause Practitioner
Publications & Presentations
PubMed
- Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.Beverly G Tchang, Michael G Knight, Kasper Adelborg, Jennifer N Clements, Aske Thorn Iversen
Obesity. 2025-02-01 - Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report.Alice S Zhao, Yi Liu, Joseph J Mulvey, Beverly G Tchang
Osteoporosis International. 2024-11-01 - 1 citationsNavigating the Predictive Landscape: DiaRem's Role in Unveiling Outcomes for Diabetes Remission following ESG.Ali Lahooti, Anam Rizvi, Andrew Canakis, Cynthia Akagbosu, Kate E Johnson
Obesity Surgery. 2024-09-01
Authored Content
- Obesity Management - A Clinical Casebook, Chapters 11-12January 2019
Press Mentions
- Ozempic May Be Linked to Cause of Sudden Blindness, Another Study ShowsDecember 23rd, 2024
- What to Know About the New Heart Disease Risk MeasurementOctober 25th, 2024
- Tirzepatide Shortage Resolved? FDA Says Yes, Compounders NoOctober 7th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: